Consuming excessive salt is a habit deeply embedded in modern dietary patterns across the globe, and for decades, public health authorities have warned of its clear link to hypertension and cardiovascular strain. However, emerging scientific evidence suggests that the dangers of a high-salt diet (HSD) extend far beyond the heart and blood vessels. Growing research indicates that chronic salt overconsumption may also jeopardize cognitive function, memory, and emotional well-being, potentially accelerating age-related decline. As the medical community grapples with the long-term neurological consequences of dietary choices, a research team in Japan has identified a potential therapeutic avenue: a soy-derived compound known as LPC70.
A recent study published in Volume 197 of Neurochemistry International on July 1, 2026, with an online release on May 14, 2026, sheds new light on how this compound, a specific form of soy lysolecithin, may counteract the systemic damage caused by high salt intake. By influencing complex chemical signaling pathways in both the kidneys and the brain, LPC70 appears to offer a dual-action protective effect that could one day inform new nutritional strategies to promote brain health and cardiovascular stability.
The Mechanism: Prostaglandins and Signaling Molecules
At the heart of the research is the study of prostaglandins (PGs)—signaling molecules synthesized from arachidonic acid, a polyunsaturated fatty acid. In the human body, prostaglandins function much like localized hormones, orchestrating a wide array of physiological processes. Within the cardiovascular system, they play a critical role in blood pressure regulation by modulating the constriction and dilation of blood vessels.
In the brain, however, their function is far more nuanced. Depending on the specific receptors they activate, prostaglandins can either exert a neuroprotective effect or initiate pathways that lead to cellular harm. This delicate balance is vital for cognitive processes, including memory formation, executive thinking, and emotional regulation.
LPC70 is a specialized ingredient where lysophosphatidylcholine (LPC) accounts for more than 70% of the phospholipids. While previous studies had hinted that LPC70 could mitigate salt-related hypertension and cognitive impairment in animal models, the underlying biological mechanisms—particularly how the compound modulates prostaglandin signaling—remained largely unknown. To bridge this gap, a research team led by Professor Akihiro Mouri and Dr. Hisayoshi Kubota, in collaboration with Dr. Kazuhiro Kagotani, set out to map the compound’s precise impact on these chemical pathways.
The researchers, affiliated with the Department of Regulatory Science for Evaluation and Development of Pharmaceuticals & Devices at Fujita Health University Graduate School of Medical Science, the International Center for Brain Science (ICBS) at Fujita Health University, and the Tsuji Health and Beauty Science Laboratory at Mie University, conducted a rigorous series of experiments on mice. Dr. Kubota, the study’s first author, oversaw the assessment of blood pressure, the monitoring of behavioral changes, and the molecular analysis of prostaglandin activity, providing a clearer picture of how the compound interacts with various organ systems.
Behavioral and Cardiovascular Improvements in Mice
The researchers began by subjecting mice to a high-salt diet, which, as anticipated, resulted in significantly elevated blood pressure. However, the systemic impact of the salt-heavy diet was not limited to the cardiovascular system. Behavioral observations revealed that the salt-exposed mice displayed a marked decline in social interaction and struggled with object recognition memory tests—clear indicators of impaired cognitive and social functioning. Notably, their basic locomotor activity and anxiety levels remained largely unchanged, suggesting that excessive salt selectively targets higher-order cognitive and social processes rather than causing generalized behavioral dysfunction.
When the team introduced LPC70 into the mice’s diet, the results were striking. The supplemented animals showed a notable reduction in blood pressure and performed significantly better on tests of social behavior and memory. These positive outcomes prompted the team to investigate the specific molecular changes occurring within the kidneys and the prefrontal cortex—a brain region central to complex thought and social awareness.
Differential Protective Effects in Kidneys and Brain
The molecular analysis revealed that LPC70 operates through a highly selective, organ-specific mechanism. In the kidneys, a high-salt diet was found to increase the expression of cyclooxygenase-2 (COX-2) and the PGE2 receptor EP3, two components associated with the development of hypertension. LPC70 treatment effectively reversed these increases, suggesting the compound helps restore homeostatic signaling in the kidneys, thereby preventing the pathological rise in blood pressure.
In the prefrontal cortex, the researchers observed a different trend. High salt consumption was linked to a decrease in the expression of the PGD2 receptor DP1, which is associated with neuroprotective and anti-inflammatory signaling. By supplementing with LPC70, the researchers successfully restored DP1 expression. Crucially, the compound did not affect the expression of DP2, a receptor often linked to harmful neuroinflammatory processes. This selectivity is significant, as it suggests that LPC70 does not indiscriminately suppress or amplify prostaglandin activity, but rather favors pathways that protect neural integrity.
Unexpected Insights into Arachidonic Acid Efficiency
One of the most intriguing findings involved the metabolic utilization of arachidonic acid. Despite the fact that mice on a high-salt diet exhibited lower levels of circulating arachidonic acid, the administration of LPC70 actually led to an increase in PGE2 and PGD2—the very prostaglandins derived from that fatty acid.
This counterintuitive result suggests that LPC70 may improve the efficiency with which the body converts available arachidonic acid into beneficial prostaglandins under the stress of high-salt conditions. By optimizing this conversion process, the compound appears to help the body maintain protective signaling even when the raw materials for those signals are depleted by salt-induced metabolic stress.
Future Implications for Human Health
The findings underscore the potential of functional food ingredients like LPC70 to serve as a prophylactic or therapeutic tool against the systemic damage caused by modern, high-sodium diets. According to Professor Mouri, the research provides a foundational understanding of how LPC70 coordinates changes in prostaglandin signaling across different organ systems.
"Our study originated from a collaborative research project with Tsuji Oil Mills Co., Ltd, a company that develops naturally derived food ingredients," Prof. Mouri noted. "Our study elucidates LPC70’s role in PG signaling, laying the groundwork for future clinical research and dietary interventions aimed at reducing hypertension-related cognitive decline and promoting healthy aging globally."
While the results are promising, the research team emphasizes that these conclusions are currently based on animal models. Translating these findings to human populations will require extensive clinical trials to determine safety, efficacy, and the precise dosages required to achieve similar cognitive and cardiovascular benefits. Nevertheless, the study offers a compelling look at how nutritional science can provide targeted interventions for complex, lifestyle-related health concerns.
The research was supported by a variety of institutions, including the Japan Society for the Promotion of Science (JSPS), which provided several Grants-in-Aid for Scientific Research. Additional support was provided by the Fujita Mind-Brain Research & Innovation Center for Drug Generation (Fujita Mind-BRIDGe) under Japan’s Peak Research Universities (J-PEAKS) Program, as well as the Japan Science and Technology Agency FOREST Program. Tsuji Oil Mills Co., Ltd. provided both funding and collaborative support, while the Education and Research Facility of Animal Models for Human Diseases at Fujita Health University, the Smoking Research Foundation, and the Takeda Science Foundation also contributed to the realization of this study.
As the global population ages and the prevalence of diet-related chronic conditions continues to rise, the ability to mitigate the subtle, long-term damage of common dietary habits—such as high salt consumption—is becoming a priority for preventive medicine. By identifying the molecular pathways through which soy-derived compounds influence the brain and kidneys, scientists are moving closer to a more nuanced, scientifically grounded approach to nutrition that may eventually help preserve cognitive health in an era of processed, salt-heavy diets.
